PCN46 ECONOMIC EVALUATION OF ONCOTYPE DX TO TARGET CHEMOTHERAPY USE IN LYMPH-NODE-NEGATIVE, OESTROGENRECEPTOR-POSITIVE, EARLY-STAGE BREAST CANCER IN IRELAND
Nov 1, 2010, 00:00
10.1016/S1098-3015(11)71942-8
https://www.valueinhealthjournal.com/article/S1098-3015(11)71942-8/fulltext
Title :
PCN46 ECONOMIC EVALUATION OF ONCOTYPE DX TO TARGET CHEMOTHERAPY USE IN LYMPH-NODE-NEGATIVE, OESTROGENRECEPTOR-POSITIVE, EARLY-STAGE BREAST CANCER IN IRELAND
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)71942-8&doi=10.1016/S1098-3015(11)71942-8
First page :
A259
Section Title :
RESEARCH POSTER ABSTRACTS
Open access? :
No
Section Order :
98